Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2707]
News [7018]
Articles [265]
Editorials [8]
Conferences [213]
elearning [41]
Thrombosis risk and management in multiple myeloma
Dr Joseph Mikhael - Chief Medical Officer of the International Myeloma...
Thrombosis risk and management in multiple myeloma ( Dr Joseph Mikhael - Chief Medical Officer of the International Myeloma Foundation )
2 May 2018
Diagnosis and management of smouldering myeloma
Prof Maria-Victoria Mateos - University Hospital of Salamanca, Salamanca, Spain
Diagnosis and management of smouldering myeloma ( Prof Maria-Victoria Mateos - University Hospital of Salamanca, Salamanca, Spain )
2 May 2018
The evolution of imaging techniques for multiple myeloma
Dr Elena Zamagni - Bologna University School of Medicine, Bologna, Italy
The evolution of imaging techniques for multiple myeloma ( Dr Elena Zamagni - Bologna University School of Medicine, Bologna, Italy )
2 May 2018
Navigating through the changing treatment landscape of advanced prostate cancer
Prof Heather Payne, Dr Luis Martinez-Piñeiro, Prof Woet Gianotten, Prof Álvaro...
Navigating through the changing treatment landscape of advanced prostate cancer ( Prof Heather Payne, Dr Luis Martinez-Piñeiro, Prof Woet Gianotten, Prof Álvaro Pinto and Prof Anders Bjartell )
2 May 2018
Editor's Choice for April 2018
Prof Gordon McVie - Founding Editor, ecancer
Editor's Choice for April 2018 ( Prof Gordon McVie - Founding Editor, ecancer )
27 Apr 2018
Dose escalation of durvalumab with tremelimumab for metastatic urothelial cancer
Dr Arjun Balar - NYU Langone Medical Center, New York, USA
Dose escalation of durvalumab with tremelimumab for metastatic urothelial cancer ( Dr Arjun Balar - NYU Langone Medical Center, New York, USA )
25 Apr 2018
Neoadjuvant nivolumab for resectable lung cancer
Dr Drew Pardoll - Johns Hopkins Medicine, Baltimore, USA
Neoadjuvant nivolumab for resectable lung cancer ( Dr Drew Pardoll - Johns Hopkins Medicine, Baltimore, USA )
25 Apr 2018
Biomarkers of pembrolizumab response in head and neck cancer
Dr Tanguy Seiwert - The University of Chicago Medicine, Chicago, USA
Biomarkers of pembrolizumab response in head and neck cancer ( Dr Tanguy Seiwert - The University of Chicago Medicine, Chicago, USA )
25 Apr 2018
Safety indications in mouse models treated with full doses of MEK inhibitors...
Dr Carmine Fedele - Laura and Isaac Perlmutter Cancer Center at New York...
Safety indications in mouse models treated with full doses of MEK inhibitors and SHP099 ( Dr Carmine Fedele - Laura and Isaac Perlmutter Cancer Center at New York University Langone Medical, New York, USA )
25 Apr 2018
Impact of microbiome on head and neck cancers
Dr Young Jun Kim - Vanderbilt-Ingram Cancer Center, Nashville, USA
Impact of microbiome on head and neck cancers ( Dr Young Jun Kim - Vanderbilt-Ingram Cancer Center, Nashville, USA )
25 Apr 2018
First-in-human trial results of RET targeted BLU-667
Prof Vivek Subbiah - MD Anderson Cancer Center, Houston, USA
First-in-human trial results of RET targeted BLU-667 ( Prof Vivek Subbiah - MD Anderson Cancer Center, Houston, USA )
25 Apr 2018
Treating RET alterations with novel therapy BLU-667
Prof Vivek Subbiah - MD Anderson Cancer Center, Houston, USA
Treating RET alterations with novel therapy BLU-667 ( Prof Vivek Subbiah - MD Anderson Cancer Center, Houston, USA )
25 Apr 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation